Current:Home > MarketsThe FDA clears updated COVID-19 vaccines for kids under age 5 -SecureWealth Bridge
The FDA clears updated COVID-19 vaccines for kids under age 5
Algosensey Quantitative Think Tank Center View
Date:2025-04-08 19:55:34
U.S. regulators on Thursday cleared doses of the updated COVID-19 vaccines for children younger than age 5.
The Food and Drug Administration's decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country — at a time when children's hospitals already are packed with tots suffering from other respiratory illnesses including the flu.
"Vaccination is the best way we know to help prevent the serious outcomes of COVID-19, such as hospitalization and death," Dr. Peter Marks, FDA's vaccine chief, told The Associated Press.
Omicron-targeted booster shots made by Moderna and rival Pfizer already were open to everyone 5 and older.
The FDA now has authorized use of the tweaked shots starting at age 6 months — but just who is eligible depends on how many vaccinations they've already had, and which kind. Only about 5% of youngsters under age 5 have gotten the full primary series since vaccinations for the littlest kids began in June.
The FDA decided that:
--Children under age 6 who've already gotten two original doses of Moderna's COVID-19 vaccine can get a single booster of Moderna's updated formula if it's been at least two months since their last shot.
--Pfizer's vaccine requires three initial doses for tots under age 5 — and those who haven't finished that vaccination series will get the original formula for the first two shots and the omicron-targeted version for their third shot.
The Centers for Disease Control and Prevention is expected to sign off soon, the final step for shots to begin.
Marks said the bivalent vaccine is safe for tots and will help parents "keep the protection for those children as up to date as possible."
But children under 5 who already got all three Pfizer doses aren't yet eligible for an updated booster.
For now, "the good news is they are probably reasonably well-protected," Marks said.
The FDA expects data from Pfizer and its partner BioNTech sometime next month to determine whether those tots will need an omicron-targeted booster "and we will act on that as soon as we can," he said.
For parents who haven't yet gotten their children vaccinated, it's not too late — especially as "we are entering a phase when COVID-19 cases are increasing," Marks said.
The updated vaccines from Moderna and Pfizer are combination shots, containing half the original vaccine and half tweaked to match the BA.4 and BA.5 omicron strains that until recently were dominant. Now BA.5 descendants are responsible for most COVID-19 cases.
The CDC last month released the first real-world data showing that an updated booster, using either company's version, does offer added protection to adults. The analysis found the greatest benefit was in people who'd never had a prior booster, just two doses of the original COVID-19 vaccine — but that even those who'd had a summertime dose were more protected than if they'd skipped the newest shot.
veryGood! (12888)
Related
- EU countries double down on a halt to Syrian asylum claims but will not yet send people back
- Lionel Messi's MLS title chase could end in first round. There's no panic from Inter Miami
- A New Nonprofit Aims to Empower Supporters of Local Renewable Energy Projects
- Which celebs are supporting Harris and Trump? Beyoncé, Taylor Swift, Amber Rose, Jason Aldean, more
- DoorDash steps up driver ID checks after traffic safety complaints
- Georgia judge rejects GOP lawsuit trying to block counties from accepting hand-returned mail ballots
- 2024 MLB Gold Glove Award winners: Record-tying 14 players honored for first time
- Takeaways from AP’s report on how immigration transformed a Minnesota farm town
- Residents worried after ceiling cracks appear following reroofing works at Jalan Tenaga HDB blocks
- Cardinals rush to close State Farm Stadium roof after unexpected hail in second quarter
Ranking
- Justice Department, Louisville reach deal after probe prompted by Breonna Taylor killing
- ‘Venom 3’ tops box office again, while Tom Hanks film struggles
- Instagram video blurry? Company heads admits quality is degraded if views are low
- Doctors left her in the dark about what to expect. Online, other women stepped in.
- The FBI should have done more to collect intelligence before the Capitol riot, watchdog finds
- Chris Olave injury update: Saints WR suffers concussion in Week 9 game vs. Panthers
- Competing Visions for U.S. Auto Industry Clash in Presidential Election, With the EV Future Pressing at the Border
- Romanchuk wins men’s wheelchair race at NYC Marathon, Scaroni wins women’s event
Recommendation
The Grammy nominee you need to hear: Esperanza Spalding
19 Things Every Grown-up Bathroom Should Have
Predicting the CFP rankings: How will committee handle Ohio State, Georgia, Penn State?
A Rural Arizona Community May Soon Have a State Government Fix For Its Drying Wells
NHL in ASL returns, delivering American Sign Language analysis for Deaf community at Winter Classic
Nebraska starts November fade with UCLA loss to lead Misery Index for Week 10
Georgia judge rejects GOP lawsuit trying to block counties from accepting hand-returned mail ballots
Dak Prescott injury update: Cowboys QB shares outlook for next week vs. Eagles